[1]
Papp, K.A., Yeung, J., Shear, N., Albrecht, L., Lynde, C., Zhang, J., Zhao, Y., Parno, J., Mendelsohn, A.M. and Gooderham, M. 2020. Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s41. DOI:https://doi.org/10.25251/skin.4.supp.41.